Moderna Partners with Recordati on mRNA-3927 for Rare Propionic Acidemia
Moderna Inc. (NASDAQ: MRNA) announced a global partnership with Italy‑based Recordati for mRNA-3927, an investigational mRNA...
Recordati
Hainan Boao Lecheng Partners with Recordati on Rare Disease Drug Development
The Hainan Boao Lecheng International Medical Tourism Pilot Zone has announced a strategic partnership with...